VILLA, Erica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.553
AS - Asia 14.173
EU - Europa 12.483
SA - Sud America 2.238
AF - Africa 351
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 24
Totale 63.857
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.974
SG - Singapore 4.467
GB - Regno Unito 3.690
CN - Cina 3.544
IT - Italia 2.178
BR - Brasile 1.734
HK - Hong Kong 1.582
VN - Vietnam 1.512
SE - Svezia 1.273
DE - Germania 1.242
FI - Finlandia 899
BD - Bangladesh 779
PL - Polonia 714
RU - Federazione Russa 596
TR - Turchia 561
UA - Ucraina 548
FR - Francia 484
KR - Corea 427
IN - India 295
BG - Bulgaria 269
CA - Canada 262
ID - Indonesia 214
AR - Argentina 180
MX - Messico 134
NL - Olanda 119
JP - Giappone 113
ZA - Sudafrica 103
IQ - Iraq 96
AE - Emirati Arabi Uniti 80
EC - Ecuador 69
ES - Italia 69
PK - Pakistan 68
CO - Colombia 60
BE - Belgio 58
LT - Lituania 54
EG - Egitto 52
IE - Irlanda 52
MA - Marocco 52
AT - Austria 49
VE - Venezuela 49
CL - Cile 46
MY - Malesia 45
UZ - Uzbekistan 44
KE - Kenya 41
PH - Filippine 39
SA - Arabia Saudita 36
NP - Nepal 35
JO - Giordania 33
CR - Costa Rica 31
PE - Perù 31
PY - Paraguay 30
BZ - Belize 26
DZ - Algeria 26
AU - Australia 25
CZ - Repubblica Ceca 25
TN - Tunisia 23
UY - Uruguay 21
JM - Giamaica 20
RO - Romania 20
HN - Honduras 18
IL - Israele 18
TH - Thailandia 18
AZ - Azerbaigian 17
CH - Svizzera 17
IR - Iran 17
AL - Albania 16
BO - Bolivia 16
DK - Danimarca 16
EU - Europa 16
GT - Guatemala 16
DO - Repubblica Dominicana 15
LB - Libano 15
RS - Serbia 14
GE - Georgia 13
HU - Ungheria 13
KZ - Kazakistan 13
QA - Qatar 13
TT - Trinidad e Tobago 13
OM - Oman 12
BH - Bahrain 11
ET - Etiopia 11
LV - Lettonia 10
PA - Panama 10
SK - Slovacchia (Repubblica Slovacca) 10
TW - Taiwan 10
NZ - Nuova Zelanda 9
SI - Slovenia 9
BY - Bielorussia 8
PR - Porto Rico 8
SN - Senegal 8
AO - Angola 7
NI - Nicaragua 7
KG - Kirghizistan 6
SV - El Salvador 6
AM - Armenia 5
GR - Grecia 5
LA - Repubblica Popolare Democratica del Laos 5
PT - Portogallo 5
CY - Cipro 4
GA - Gabon 4
Totale 63.762
Salva come PNG Salva come JPEG
Città #
Fairfield 3.544
Ashburn 3.437
Santa Clara 2.922
Singapore 2.729
Southend 2.383
Woodbridge 1.967
Houston 1.913
Chandler 1.659
Hong Kong 1.532
Seattle 1.358
Wilmington 1.216
Cambridge 1.122
Ann Arbor 1.069
Jacksonville 1.021
Hefei 966
San Jose 955
New York 927
Dearborn 789
Nyköping 739
Helsinki 734
London 710
Warsaw 687
Beijing 617
Los Angeles 597
Modena 544
Chicago 531
Ho Chi Minh City 480
Council Bluffs 471
The Dalles 406
Izmir 377
Hanoi 368
Seoul 339
San Diego 317
Princeton 268
Sofia 260
Grafing 255
Lauterbourg 232
Buffalo 227
Milan 222
Shanghai 198
Salt Lake City 195
Eugene 183
Moscow 169
São Paulo 169
Jersey City 157
Jakarta 154
Dallas 151
Munich 133
Redwood City 130
Des Moines 113
Tampa 102
Orem 101
Columbus 97
Tokyo 94
Frankfurt am Main 89
Bremen 87
Elk Grove Village 82
Rome 78
Phoenix 72
Atlanta 70
Boardman 69
Bologna 67
North Bergen 67
Brooklyn 64
Rio de Janeiro 64
Da Nang 60
Bupyeong-gu 59
Redondo Beach 59
Guangzhou 58
Montreal 58
Brussels 54
Toronto 54
Haiphong 53
Chennai 52
Johannesburg 52
San Mateo 50
Naples 48
Denver 47
Dublin 47
Falls Church 47
Norwalk 47
Miano 46
Philadelphia 46
Belo Horizonte 43
Mexico City 43
Nanjing 42
Kent 41
Nuremberg 41
Tashkent 41
Baghdad 40
Sterling 37
Fremont 35
Nairobi 34
Charlotte 33
San Francisco 33
Vancouver 32
Brasília 31
Dhaka 31
Paris 31
Mumbai 30
Totale 45.400
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 705
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 631
AISF position paper on liver disease and pregnancy 599
Non-alcoholic steatohepatitis and liver transplantation 524
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 458
Intestinal/multivisceral transplantation: University of Modena experience 455
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 444
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 442
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 439
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 426
Orthogonal polarization spectral imaging: A new tool in morphologic surveillance in intestinal transplant recipients 409
Coagulopathy in liver diseases: complication or therapy? 403
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 401
Outcomes after adult isolated small bowel transplantation: experience from a single European centre. 394
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 390
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 387
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times 386
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C 381
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 379
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 378
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 376
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 364
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial 363
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. 355
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 353
Alcohol and Hepatitis B Virus Infection 350
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 349
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 348
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. 347
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis 337
Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy 331
Fulminant onset of spontaneous bacterial peritonitis. 328
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 323
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 323
Variant estrogen receptors and their role in liver disease 321
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 316
Hepatic allograft salvage with early Doppler ultrasound diagnosis of acute vena cava thrombosis 314
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 314
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 312
High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: Long term results of a prospective randomized trial 311
Hepatocellular carcinoma - Role of estrogen receptors in the liver 308
Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses 308
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 307
Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. 307
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 305
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 304
Ethanol-induced increase in cytosolic estrogen receptors in human male liver: a possible explanation for biochemical feminization in chronic liver disease due to alcohol. 302
Gastrointestinal endoscopy and HBV infection: no evidence for a causal relationship. A prospective controlled study. 301
Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study 301
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 299
Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma 298
Phytoestrogens and liver disease 298
Estrogen receptor classification for hepatocellular carcinoma: Comparison with clinical staging systems 297
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women 297
From current status to optimization of HCV treatment: Recommendations from an expert panel 297
Reproductive status is associated with the severity of fibrosis in women with hepatitis C. 297
Missed treatment in an Italian HBV infected patients cohort: HBV RER 295
Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol. 295
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 294
Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantation 293
Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients. 292
Obese zebrafish: A small fish for a major human health condition 292
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 289
Clinical staging systems for hepatocellular carcinoma: Comparison with estrogen receptor classification 288
HEPATITIS-C VIRUS TESTING IN PRIMARY BILIARY-CIRRHOSIS 288
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 286
HEPATITIS-B VIRUS SPECIFIC TRANSCRIPTS IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS 281
Flow-dependent shear stress affects the biological properties of pericyte-like cells isolated from human dental pulp 280
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 279
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 278
Influence of age and gender before and after liver transplantation 277
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 277
Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant 274
EVIDENCE FOR HEPATITIS-B VIRUS-INFECTION IN PATIENTS WITH CHRONIC HEPATITIS-C WITH AND WITHOUT SEROLOGICAL MARKERS OF HEPATITIS-B 274
Massive GI bleeding due to accidental ASA inhalation. 273
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 273
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 273
Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors 272
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 272
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 271
Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection. 268
Beneficial hemodynamic effects of dipyridamole on portal circulation in cirrhosis 267
Interleukin 28B genotype determination using DNA from different sources: A simple and reliable tool for the epidemiological and clinical characterization of hepatitis C. 267
Estrogens receptors and oxidative damage in the liver 266
No inflammation? No cancer! Clear HBV early and live happily. 265
Sex hormones and liver cancer 264
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? 261
Hepatitis B virus infection of peripheral blood mononuclear cells is common in acute and chronic hepatitis. 261
Treatment of nonalcoholic steatohepatitis in adults: present and future 260
Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival 260
"Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not? 259
BactDNA as an Independent Risk Factor for Short-Term Crohn's Disease Recurrence 259
Impact of a Multidisciplinary Team on Alcohol Recidivism and Survival After Liver Transplant for Alcoholic Disease 256
Androgen receptor alterations in hepatocarcinogenesis. 255
Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study 255
Successful liver transplantation in a patient with splanchnic vein thrombosis and pulmonary embolism due to polycythemia vera with Jak2v617f mutation and heparin-induced thrombocytopenia. 255
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results 255
Anticoagulation in cirrhosis: a new paradigm? 253
PRESENCE OF HCV RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS INVOLVED IN POSTTRANSFUSION HEPATITIS (PTH) 252
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury 252
Totale 32.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 258.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 258.255
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.917 334 550 347 283 133 262 508 267 502 407 847 477
2022/20234.584 561 524 353 437 502 712 62 421 537 45 202 228
2023/20242.629 117 177 210 279 458 221 239 327 67 54 155 325
2024/202510.264 337 99 139 732 2.050 1.521 613 678 1.466 655 845 1.129
2025/202621.219 1.243 717 1.580 2.344 2.980 2.666 2.271 1.058 1.831 1.758 1.636 1.135
2026/2027686 686 0 0 0 0 0 0 0 0 0 0 0
Totale 64.284